Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis (Q37637758)

21 August 2017

0 references

1 reference

title

Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis (English)

1 reference

21 August 2017

0 references

1

Ioannis A Bliziotis

1 reference

21 August 2017

4

Matthew E Falagas

1 reference

21 August 2017

Eleni Plessa

2

1 reference

PubMed ID

19934396

21 August 2017

George Peppas

series ordinal

3

1 reference

PubMed ID

19934396

21 August 2017

language of work or name

English

0 references

publication date

24 November 2009

1 reference

Annals of Pharmacotherapy

21 August 2017

1 reference

21 August 2017

44

1 reference

21 August 2017

1

1 reference

21 August 2017

97-106

1 reference

National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections

21 August 2017

1 reference

Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone

21 January 2018

1 reference

A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections

21 January 2018

1 reference

Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic

21 January 2018

1 reference

Treatment challenges in the management of complicated skin and soft-tissue infections

21 January 2018

1 reference

Daptomycin: a cyclic lipopeptide antimicrobial agent

21 January 2018

1 reference

In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria

21 January 2018

1 reference

The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas

21 January 2018

1 reference

Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes

21 January 2018

1 reference

Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections.

21 January 2018

1 reference

Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections

21 January 2018

1 reference

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial

21 January 2018

1 reference

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

21 January 2018

1 reference

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

21 January 2018

1 reference

Resistance studies with daptomycin

21 January 2018

1 reference

Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).

21 January 2018

1 reference

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

Diagnosis and treatment of diabetic foot infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M264

1 reference

21 August 2017

1 reference

PubMed ID

19934396